Atlas Trials

Omeprazole and Reflux Disease - Improvement of Clinical Outcome by Genotype-adjusted Dosing

Clinical trial NCT00537732 · TERMINATED

Trial details

NCT number
NCT00537732
Sponsor
Matthias Schwab
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Gastroesophageal Reflux
Start date
2007-04-01
Primary completion
2010-12-01
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.